AI & Blockchain-Based Motion Analytics by DorsaVi

Overview: DorsaVi is an innovative technology company specialising in wearable sensor solutions and Video AI data analytics to understand and optimise human movement. Headquartered in Melbourne, Australia, the company serves a global clientele across healthcare, workplace ergonomics, and sports performance sectors. DorsaVi’s proprietary technology combines advanced sensors with data-driven insights to deliver actionable outcomes for injury prevention, rehabilitation, and performance improvement. With a reputation for pioneering solutions, the company is now expanding its capabilities by integrating blockchain technology, solidifying its position as a leader in secure and transparent data management in human movement.

Recent Updates for DorsaVi:

Leadership and Funding: Appointed key leaders, including Dr. Michael Winlo, Vineet Agarwal as Non-Executive Directors and Aaron Chan as CFO.

DorsaVi Appoints Leigh Travers as Non-Executive Director: DorsaVi has appointed Leigh Travers to its Board of Directors, effective December 4, 2024, reinforcing its commitment to innovation and strategic growth.Travers, currently Director of Emerging Markets at Animoca Brands, brings deep expertise in blockchain and public markets. He previously served as CEO of Binance Australia (2021–2023) and DigitalX Limited (ASX: DCC) and has held leadership roles in investment and technology firms on NASDAQ and TSX. A key figure in blockchain adoption, he has advised multiple unicorn startups and served as Director and Treasurer of Australia’s blockchain industry body.

Strategic Value to DorsaVi: DorsaVi continues to revolutionize movement analysis with its Video AI and 3D motion analysis technology, eliminating the need for physical sensors while delivering real-time, AI-driven insights. The newly launched FDAcleared 3D motion analysis test addresses the $7 billion U.S. ACL injury prevention market, enhancing athlete safety, rehabilitation, and workplace injury prevention.

Share Price: 0.009

ASX: DVL
Sector: Healthcare and Pharma
18 March 2025

ASX: DVL Share price (A$)

This high-margin (>70%) SaaS model is scalable across physical therapy, sports performance, and workplace safety, leveraging blockchain-enhanced privacy for data security. Following strong beta adoption, Video AI remains a key growth driver, complementing DorsaVi’s 3D motion tracking solutions to disrupt the $47.59 billion U.S. physical therapy market.

The appointment of Leigh Travers as a Non-Executive Director aligns with DorsaVi’s vision to integrate advanced technologies into digital healthcare. His expertise in blockchain, Web3, and fintech will:

  • Enhance AI Capabilities: Expand AI-driven healthcare applications with real-time insights.
  • Unlock Strategic Partnerships: Leverage his global network for investment and collaboration.
  • Broaden Market Reach: Position DorsaVi within emerging markets and disruptive health tech ecosystems.

With its AI-driven 3D motion analysis and Video AI, DorsaVi is reshaping movement science, ensuring better injury prevention, recovery, and performance optimization for athletes and clinicians alike.